Thursday 28th of October 2021

Follow Us

Breaking News

Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine

 (FAST MAIL NEWS) - Johnson & Johnson (NYSE: JNJ) (the Company) today announced data supporting the use of its COVID-19 vaccine as a booster shot for people previously vaccinated with the single-shot Johnson & Johnson vaccine.

 

In July, the Company reported interim Phase 1/2a data published in the New England Journal of Medicine that demonstrated neutralizing antibody responses generated by the Johnson & Johnson single-shot COVID-19 vaccine were strong and stable through eight months after immunization.

 

In anticipation of the potential need for boosters, the Company conducted two Phase 1/2a studies in individuals previously vaccinated with its single-shot vaccine. New interim data from these studies demonstrate that a booster dose of the Johnson & Johnson COVID-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination. Significant increases in binding antibody responses were observed in participants between ages 18 and 55, and in those 65 years and older who received a lower booster dose. The study summaries were submitted to medRxiv on August 24.

 

 

 

 "We have established that a single shot of our COVID-19 vaccine generates strong and robust immune responses that are durable and persistent through eight months. With these new data, we also see that a booster dose of the Johnson & Johnson COVID-19 vaccine further increases antibody responses among study participants who had previously received our vaccine," said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, Johnson & Johnson. "We look forward to discussing with public health officials a potential strategy for our Johnson & Johnson COVID-19 vaccine, boosting eight months or longer after the primary single-dose vaccination."

 

The Company is engaging with the U.S. Food and Drug Administration (FDA), U.S. Centers for Disease Control and Prevention (CDC), European Medicines Agency (EMA) and other health authorities regarding boosting with the Johnson & Johnson COVID-19 vaccine. Johnson & Johnson continues to diligently generate and evaluate data from ongoing trials as well as emerging real-world evidence.

 

The Phase 1/2a clinical trials (VAC31518COV1001 and VAC31518COV2001) have been funded in part with federal funds from the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA), under other transaction authority ("OTA") agreement No. HHSO100201700018C.

Related US & Latin America News

First Lady Calls Military Spouse Employment a National Security Imperative

 Washingtn,FASTMAIL - As the Military Spouse Employment Partnership turns 10 years old, First Lady Dr. Jill Biden said military spouse employment is a national security imperative.  Speaking today at the virtual 2021 Annual Official Opening Event and New Partner Induction Ceremony, Biden e....

U.S. Government Still Working to Evacuate Afghans

 Washington,FASTMAIL –US Secretary of Defense Lloyd J. Austin III  said in Brussels "We continue to work to ensure that those people who have helped us have the opportunity to leave the country if they so desire." Kirby told reporters Austin was referring to the larger U.S.....

2 dead, 5 wounded in US mall shooting

 Washington,FASTMAIL -Two people were killed and at least five others wounded, including a police officer, in a shooting Monday at a mall in the US state of Idaho, police said. The incident occurred in the afternoon at the Boise Towne Square Mall in the city of Boise. At a press conference, Boi....

DoD Releases Report on Defense Spending by State in Fiscal Year 2020

 Washington<FASTMAIL -The Department of Defense’s Office of Local Defense Community Cooperation (formerly the Office of Economic Adjustment) released its Fiscal Year 2020 Defense Spending by State report to help states and communities better understand the components of defense spendin....

US Defence Secretary Participates in the NATO Defense Ministerial Meeting

 Washington, FASTMAIL -Secretary of Defense Lloyd J. Austin III participated in his first in-person NATO Defense Ministerial on October 21-22 hosted by NATO Secretary General Jens Stoltenberg.  This visit marked the end of his regional trip, and enabled further discussion on security issue....

Links
Contact
Editor :
Jagadananda Pradhan
Email :
fastmail@yahoo.com
For Ads :
fastmailads@gmail.com
Ph : (+91)6764295999
Contact Us
© 2021 Fast Mail Media Pvt Ltd. All Rights Reserved.
Developed by : FM Media Pvt Ltd.